Glaukos Corp (GKOS): Next-Year EPS Estimate 185.94%
As of 2026-06-04, Glaukos Corp (GKOS) has a next-year EPS growth estimate of 185.94%.
GKOS was first flagged by our screen on 2026-05-26, when analyst consensus for its next-year EPS growth was revised from 185.92% to 185.99%. Current-year growth is projected at 42.86%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 185.94%
- EPS growth this year
- 42.86%
- EPS next quarter (est)
- -$0.21
- Last price
- $121.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 185.94% | 42.86% | -$0.21 | $121.69 |
| 2026-06-03 | 185.92% | 42.89% | -$0.21 | $113.64 |
| 2026-06-02 | 185.92% | 42.89% | -$0.21 | $110.78 |
| 2026-06-01 | 185.99% | 42.92% | -$0.21 | $103.12 |
| 2026-05-31 | 185.99% | 42.92% | -$0.21 | $103.35 |
| 2026-05-28 | 185.99% | 42.92% | -$0.21 | $106.52 |
| 2026-05-27 | 185.99% | 42.92% | -$0.21 | $109.88 |
| 2026-05-26 | 185.99% | 42.92% | -$0.21 | $114.97 |
| 2026-05-25 | 185.92% | 42.89% | -$0.21 | $120.23 |
| 2026-05-24 | 185.92% | 42.89% | -$0.21 | $120.23 |
| 2026-05-21 | 185.92% | 42.89% | -$0.21 | $139.03 |
| 2026-05-20 | 185.96% | 42.90% | -$0.21 | $143.82 |
| 2026-05-19 | 185.96% | 42.90% | -$0.21 | $139.90 |
| 2026-05-18 | 185.96% | 42.90% | -$0.21 | $142.18 |
| 2026-05-17 | 185.96% | 42.90% | -$0.21 | $144.01 |
| 2026-05-14 | 185.68% | 42.81% | -$0.21 | $142.15 |
| 2026-05-13 | 185.71% | 42.84% | -$0.21 | $137.50 |
| 2026-05-12 | 185.71% | 42.84% | -$0.21 | $136.36 |
| 2026-05-11 | 185.71% | 42.84% | -$0.21 | $135.37 |
| 2026-05-10 | 185.71% | 42.84% | -$0.21 | $133.52 |
| 2026-05-07 | 185.71% | 42.84% | -$0.21 | $134.15 |
| 2026-05-06 | 185.71% | 42.84% | -$0.21 | $135.27 |
| 2026-05-05 | 185.71% | 42.84% | -$0.21 | $133.42 |
| 2026-05-04 | 185.71% | 42.84% | -$0.21 | $135.85 |
| 2026-05-03 | 184.87% | 42.30% | -$0.21 | $140.22 |
| 2026-04-30 | 184.87% | 42.30% | -$0.21 | $143.67 |
| 2026-04-29 | 179.39% | 39.60% | -$0.28 | $116.96 |
| 2026-04-28 | 179.39% | 39.60% | -$0.28 | $119.63 |
| 2026-04-27 | 179.39% | 39.60% | -$0.28 | $122.07 |
| 2026-04-26 | 179.39% | 39.60% | -$0.28 | $121.48 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Glaukos Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Glaukos Corp (GKOS) has a next-year EPS growth estimate of 185.94%, based on analyst consensus.
When was the latest EPS estimate revision for GKOS?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 185.92% to 185.94%.
What sector and industry does Glaukos Corp belong to?▾
Glaukos Corp operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GKOS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Glaukos Corp (GKOS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports